281 related articles for article (PubMed ID: 28618919)
1. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
Hammond DA; McCain K; Painter JT; Clem OA; Cullen J; Brotherton AL; Chopra D; Meena N
J Intensive Care Med; 2019 Oct; 34(10):805-810. PubMed ID: 28618919
[TBL] [Abstract][Full Text] [Related]
2. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
[TBL] [Abstract][Full Text] [Related]
3. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
Sacha GL; Lam SW; Duggal A; Torbic H; Reddy AJ; Bauer SR
Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496
[TBL] [Abstract][Full Text] [Related]
4. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function.
Taylor A; Jones T; Forehand CC; Smith SE; Dykes H; Newsome AS
J Pharm Pract; 2022 Dec; 35(6):879-885. PubMed ID: 33977793
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
[TBL] [Abstract][Full Text] [Related]
6. Effects of Norepinephrine and Vasopressin Discontinuation Order in the Recovery Phase of Septic Shock: A Systematic Review and Individual Patient Data Meta-Analysis.
Hammond DA; Sacha GL; Bissell BD; Musallam N; Altshuler D; Flannery AH; Lam SW; Bauer SR
Pharmacotherapy; 2019 May; 39(5):544-552. PubMed ID: 30893494
[TBL] [Abstract][Full Text] [Related]
7. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock.
Hammond DA; Cullen J; Painter JT; McCain K; Clem OA; Brotherton AL; Chopra D; Meena N
J Intensive Care Med; 2019; 34(11-12):910-916. PubMed ID: 28820036
[TBL] [Abstract][Full Text] [Related]
9. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study.
Bauer SR; Aloi JJ; Ahrens CL; Yeh JY; Culver DA; Reddy AJ
J Crit Care; 2010 Jun; 25(2):362.e7-362.e11. PubMed ID: 19926252
[TBL] [Abstract][Full Text] [Related]
10. Effects of the discontinuation sequence of norepinephrine and vasopressin on hypotension incidence in patients with septic shock: A meta-analysis.
Duclos G; Baumstarck K; Dünser M; Zieleskiewicz L; Leone M
Heart Lung; 2019; 48(6):560-565. PubMed ID: 31126701
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
12. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
Bauer SR; Sacha GL; Reddy AJ
Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
[No Abstract] [Full Text] [Related]
13. Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock.
Hammond DA; Ficek OA; Painter JT; McCain K; Cullen J; Brotherton AL; Kakkera K; Chopra D; Meena N
Pharmacotherapy; 2018 May; 38(5):531-538. PubMed ID: 29600824
[TBL] [Abstract][Full Text] [Related]
14. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
Haan BJ; Cadiz ML; Natavio AM
Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
[No Abstract] [Full Text] [Related]
16. Norepinephrine vs Vasopressin: Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis.
Wu Z; Zhang S; Xu J; Xie J; Huang L; Huang Y; Yang Y; Qiu H
Shock; 2020 Jan; 53(1):50-57. PubMed ID: 31008869
[TBL] [Abstract][Full Text] [Related]
17. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Hypotension Associated With Two Different Vasopressin Discontinuation Strategies in the Recovery Phase of Septic Shock.
Murata J; Buckley M; Lehn J; Agarwal SK; Stevenson B; Martinez B; MacLaren R
J Pharm Pract; 2023 Aug; 36(4):830-838. PubMed ID: 35331049
[No Abstract] [Full Text] [Related]
19. Incidence of Hypotension after Discontinuation of Norepinephrine or Arginine Vasopressin in Patients with Septic Shock: a Systematic Review and Meta-Analysis.
Song JU; Lee J; Park HK; Suh GY; Jeon K
J Korean Med Sci; 2020 Jan; 35(1):e8. PubMed ID: 31898435
[TBL] [Abstract][Full Text] [Related]
20. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
